CDKN2A and hepatocellular carcinoma: In addition, genomic alterations of CDKN2A identified in sarcomatoid HCC were rearrangement (3/4) and gene homozygous deletion (1/4), which would lead to the loss of function, while substitutions or short indels were the variation types identified in non‐sarcomatoid HCC cohort.